Source disclosure: February 10, 2026
KURARAY CO.,LTD. [3405.T]
TOKYO, Feb 10 (Pulse News Wire) – Kuraray CO.,LTD. (3405.T) reported lower-than-expected earnings for the fiscal year ending December 31, 2025, due to impairment losses recorded in its consolidated results.
In the fiscal year ended December 31, 2025, the company recognized impairment losses totaling ¥25.60 billion related to assets in its Isoprene Chemicals and Elastomers businesses. Specifically, the impairment loss was applied to asset groups associated with styrenic thermoplastic elastomers within the Elastomer business. Additionally, individual results included equity method investment impairments and provisions for doubtful accounts on loans to associates amounting to ¥22.60 billion and ¥13.10 billion, respectively.
Despite these adjustments, sales revenue, operating profit, and ordinary profit largely aligned with previous forecasts. However, net income attributable to parent shareholders fell below expectations due to the recognition of impairment losses as extraordinary items. Comparing the latest figures against the initial forecast released on January 1, 2025: | Item | Previous Forecast (A) | Actual Results (B) | Difference (B-A) | Variance Rate (%) | |------|-----------------------|--------------------|------------------|-------------------| | Sales Revenue | ¥810.0 billion | ¥808.4 billion | --¥1.552 billion | -0.2% | | Operating Profit | ¥60.00 billion | ¥58.88 billion | --¥1.117 billion | -1.9% | | Ordinary Profit | ¥53.00 billion | ¥51.52 billion | --¥1.485 billion | -2.8% | | Net Income Attributable to Parent Shareholders | ¥23.00 billion | ¥7.468 billion | --¥15.53 billion | -67.5% | The company's dividend outlook for the fiscal year remains unchanged from the previously announced figure of ¥27 per share on August 8, 2025.
AI-translated content. 🟢 Confidence: High See terms • Original filing